# JNPMEDI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jnpmedi

- Industry: Healthcare IT
- Headquarters: Incheon, South Korea
- Website: www.jnpmedi.com
- Total disclosed funding: $12M
- Latest round: Series A (Nov 22, 2022)
- Investors on record: 6

## About

Founded in 2020, and based in Seoul, South Korea, JNPMEDI Inc. is a pharmaceuticals company that operates a cloud-based data platform that digitalizes clinical research and trial operations. Jeon Jeong-ho is the CEO of the company. In August 2025, JNPMEDI Inc. raised an undisclosed amount in venture funding from new investors Naver and TBT Partners. The company operates Maven CDMS™, a medical data platform monitoring solution that collects, monitors, and analyzes medical data for clinical trials based on digital technologies such as blockchain and cloud technology. The enterprise's maven clinical cloud solutions include maven coder, maven EDC, maven builder, maven RTSM, maven auditor, and maven trigger. The firm provides clinical data management solutions, clinical trial management solutions, and professional services. JNPMEDI also offers management consulting, digital transformation strategy, cutting-edge tech development, clinical operations, and pharmaceuticals. The organization generates revenue through its subscription plans that include maven standard, maven professional, and maven extensive.

## Funding rounds

- Series A, Nov 22, 2022, $10M — AJU IB Investment, Pavilion Capital, Kakao Ventures, Murex Partners, Taurus Partners
- Seed, Mar 1, 2022 — AJU IB Investment, Korea Tech Incubator for Startup
- Seed, Dec 8, 2021, $1.7M — AJU IB Investment, Kakao Ventures, Murex Partners, Taurus Partners

## Investors

- AJU IB Investment (https://capitalatlas.ai/funds/aju-ib-investment) — Seed, Series A
- Kakao Ventures (https://capitalatlas.ai/funds/kakao-ventures) — Seed, Series A
- Murex Partners (https://capitalatlas.ai/funds/murex-partners) — Seed, Series A
- Taurus Partners (https://capitalatlas.ai/funds/taurus-partners) — Seed, Series A
- Korea Tech Incubator for Startup — Seed
- Pavilion Capital — Series A